Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)

9.270 -0.210 (-2.22%) At close: 03:59PM HKT

Zylox-Tonbridge Medical Technology Co., Ltd.

Zylox-Tonbridge Industrial Park
No. 270 Shuyun Road Cangqian Street Yuhang District
Hangzhou
China
86 571 8861 0082
https://www.zyloxtb.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 765

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Zhong Zhao	Founder, Chairman & CEO	6.49M	N/A	1968
Mr. Yang Xie	Senior VP of Sales & Marketing and Executive Director	3.68M	N/A	1970
Dr. Zheng Li	Senior VP, GM of Neurovascular Business & Executive Director	11.15M	N/A	1978
Mr. Quanwei Yuan	CFO & Joint Company Secretary	N/A	N/A	1980
Ms. Sau In Kwan	Joint Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices the People's Republic of China and internationally. The company develops neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. It also develops peripheral-vascular interventional product portfolio covering a spectrum of arterial and venous products comprising stents, balloons, catheters, and filters, as well as covers hemodialysis access, aortic intervention, peripheral embolization intervention, and radiological intervention products. In addition, the company provides technical consultation and services; as well as imports materials. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.

Corporate governance

Zylox-Tonbridge Medical Technology Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.